[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75164]], camposKey:0030-3747 2022-12-01 Pathophysiology of Age-Related Macular Degeneration: Implications for Treatment615636, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75596]], camposKey:0212-6567 2022-12-01 Referral criteria to clinical genetics from primary care: Consensus document Criterios de derivación a genética clínica desde Atención Primaria. Documento de consenso00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73289]], camposKey:0212-6567 2022-01-01 Criterios de derivación a genética clínica desde Atención Primaria. Documento de consenso60, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63263]], camposKey:2073-4425 2021-01-01 Genetic Profile in Genes Associated with Cardiorespiratory Fitness in Elite Spanish Male Endurance Athletes12300, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65501]], camposKey:1715-5312 2020-11-01 Genotype scores in energy and iron-metabolising genes are higher in elite endurance athletes than in nonathlete controls12251231, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54882]], camposKey:1090-0535 2020-01-01 Exome sequencing identifies PEX6 mutations in three cases diagnosed with Retinitis Pigmentosa and hearing impairment216225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63262]], camposKey:2073-4425 2020-01-01 PRPH2-Related Retinal Diseases: Broadening the Clinical Spectrum and Describing a New Mutation7730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54883]], camposKey:1129-2369 2019-01-01 CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54885]], camposKey:2198-9761 2019-01-01 Liver-Metabolizing Genes and Their Relationship to the Performance of Elite Spanish Male Endurance Athletes; a Prospective Transversal Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49459]], camposKey:0197-4580 2019-01-01 Novel presenilin 1 mutation (p.Thr-Pro116-117Ser-Thr) in a Spanish family with early-onset Alzheimer's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44484]], camposKey:1139-1626 2018-01-01 Alteraciones orodentales en el Síndrome de Bloch-Sulzberger: Revisión bibliográfica108119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47734]], camposKey:0019-9567 2018-01-01 Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49460]], camposKey:0001-6519 2017-01-01 Autosomal dominant auditory neuropathy and variant DIAPH3 (c.-173C>T) Neuropatía auditiva autosómica dominante y variante DIAPH3 (c.-173C>T)183185, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54886]], camposKey:2090-6668 2016-01-01 Familial Hemiplegic Migraine with Severe Attacks: A New Report with ATP1A2 Mutation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49461]], camposKey:0025-7753 2016-01-01 Relevance of new genetic tests in the diagnosis of short stature with dysmorphic features Relevancia de las nuevas pruebas genéticas en el diagnóstico de la talla baja con dismorfias00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56015]], camposKey:1569-1993 2015-01-01 Cystic fibrosis neonatal screening in Castilla-León (Spain), a fifteen years experience00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44483]], camposKey:2444-7986 2015-01-01 Importancia de las pruebas genéticas en la hipoacusia infantil1930, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60016]], camposKey:0271-5333 2015-01-01 Nonvascular post¿liver transplantation complications: From us screening to crosssectional and interventional imaging87104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60018]], camposKey:0361-803X 2014-03-01 Nontraumatic acute aortic emergencies: Part 1, acute aortic syndrome656665, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60017]], camposKey:0361-803X 2014-03-01 Nontraumatic acute aortic emergencies: Part 2, pre-and postsurgical complications related to aortic aneurysm in the emergency clinical setting666674, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44486]], camposKey:0210-5691 2014-01-01 TLR2-TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae356362, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20882]], camposKey:0300-8932 2011-01-01 El polimorfismo R753Q del toll-like receptor 2 se asocia a un aumento en el riesgo de sufrir endocarditis infecciosa10561059, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49462]], camposKey:0025-7753 2011-01-01 Ethics on genetic research (2). Genetic susceptibility studies Ética en investigación genética (2). Estudios de susceptibilidad2226, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48357]], camposKey:0300-8932 2011-01-01 Toll-like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis El polimorfismo R753Q del toll-like receptor 2 se asocia a un aumento en el riesgo de sufrir endocarditis infecciosa10561059, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10058]], camposKey:1120-6721 2010-01-01 PRPH2 (Peripherin/RDS) mutations associated with different macular dystrophies in a Spanish population: a new mutation724732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56019]], camposKey:1569-1993 2009-01-01 CFTR mutations detected in neonates with hypertrypsinemia through the CF newborn screening program in Castilla-León (Spain) since 199900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37901]], camposKey:0954-6111 2008-01-01 ALOX5 promoter genotype and response to montelukast in moderate persistent asthma857861, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53052]], camposKey:0146-0404 2008-01-01 Analysis of Peripherin-rds in Isolated Cases and Spanish Families Presenting Different Macular Dystrophies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49463]], camposKey:0003-4800 2007-01-01 Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry194201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58427]], camposKey:0210-0010 2006-12-01 Autosomal recessive diseases with mental retardation Enfermedades autosómicas recesivas con retraso mental00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49464]], camposKey:0210-0010 2006-01-01 Autosomal recessive diseases with mental retardation Enfermedades autosómicas recesivas con retraso mental3943, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39632]], camposKey:1395-3907 2006-01-01 Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study309313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22176]], camposKey:1695-4033 2006-01-01 Farmacogenética en el tratamiento del asma2210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49465]], camposKey:1695-4033 2006-01-01 Pharmacogenetics in the treatment of asthma Farmacogenética en el tratamiento del asma221223, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2860]], camposKey:0954-6111 2006-01-01 Tachyphylaxis to beta(2)-agonists in Spanish asthmatic patients could be modulated by beta(2)-adrenoceptor gene polymorphisms10721078, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39634]], camposKey:0146-0404 2005-01-01 Cytokine gene polymorphism in retinal detachment patients with and without proliferative vitreoretinopathy preliminary study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54884]], camposKey:1696-2818 2005-01-01 From the laboratory to the clinic: Neonatal screening for cystic fibrosis Desde el laboratorio a la clínica Cribado neonatal de la fibrosis quística168172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49466]], camposKey:0211-3465 2005-01-01 Genetics Table: Phenotype modifier genes in cystic fibrosis Mesa Genética: Genes modificadores del fenotipo en la fibrosis quística2527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49467]], camposKey:0001-6640 2004-01-01 Neonatal hyperbilirrubinemia: A peculiar presentation of alpha-1-antitrypsin deficiency Hiperbilirrubinemia neonatal. Peculiar debut del déficit de alfa-1-antitripsina163166, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54887]], camposKey:0030-3747 2002-01-01 Antisilicone antibodies in patients with silicone implants for retinal detachment surgery - Reply106106, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18295]], camposKey:0302-4342 2002-01-01 Cribado neonatal de fibrosis quística6065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78265]], camposKey:1695-4033 2002-01-01 Cribado neonatal de fibrosis quística6065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44487]], camposKey:0304-5412 2002-01-01 El asesoramiento genético44224427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49468]], camposKey:0302-4342 2002-01-01 Neonatal screening for cystic fibrosis Cribado neonatal de fibrosis quística6065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2848]], camposKey:0093-7711 2002-01-01 TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population551555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49471]], camposKey:0030-3747 2001-01-01 Antisilicone antibodies in patients with silicone implants for retinal detachment surgery8790, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49470]], camposKey:0302-4342 2001-01-01 Effectiveness of a clinical checklist in the preselection of children with suspicion of fragile X syndrome Eficacia de un test clínico como preselección de niños con sospecha de síndrome X frágil326330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=19434]], camposKey:0302-4342 2001-01-01 Eficacia de un test clínico como preselección de niños con sospecha de síndrome X frágil326330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78264]], camposKey:1695-4033 2001-01-01 Eficacia de un test clínico como preselección de niños con sospecha de síndrome X frágil326330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56024]], camposKey:1695-4033 2001-01-01 Eficacia de un test clínico como preselección de niños con sospecha de síndrome X frágilEffectiveness of a clinical checklist in the preselection of children with suspicion of fragile X syndrome326330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49469]], camposKey:1018-9068 2001-01-01 Susceptibility genes for asthma and allergy: Hits and questions7378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49472]], camposKey:1018-9068 2000-01-01 Increased TNFA*2, but not TNFB*1, allele frequency in Spanish atopic patients149154, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56021]], camposKey:1438-7506 2000-01-01 Polyvariant Mutant Genes: different haplotypes determining different alterations causing azoospermia189193, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22024]], camposKey:1138-3593 1999-01-01 Infección por "Heamophilus influenzae" en pacientes portadores del virus de la inmunodeficiencia humana121128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60019]], camposKey:1059-7794 1999-01-01 Spectrum of CFTR mutations in the Middle North of Spain and identification of a novel mutation (1341G-->A). Mutation in brief no. 252. Online.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2797]], camposKey:0277-2116 1998-01-01 Alpha-1 antichymotrypsin levels are actively increased in normal colostrum376379, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49474]], camposKey:0301-0546 1998-01-01 Fundamentos biológicos y genéticos de la atopia y el asma5973, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49407]], camposKey:0254-9670 1998-01-01 HLA-DQA1(*)0501 and DQB1(*)02 homozygosity and disease susceptibility in Spanish coeliac patients286290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54888]], camposKey:0105-4538 1998-01-01 Lack of association between atopy and RsaI polymorphism within intron 2 of the Fc(epsilon)RI-beta gene in a Spanish population sample10831086, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49475]], camposKey:0210-4806 1997-01-01 Agenesis of vas deferens and cystic fibrosis Agenesia de conductos deferentes y fibrosis quística.773776, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3292]], camposKey:0302-4342 1997-01-01 Value of salivary antibodies to assess seropositivity against measles, rubella and mumps in children and adults Valor de los anticuerpos salivares para la determinacion de la seropositividad frente a sarampion, rubeola y parotiditis en ninos y adultos499504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22025]], camposKey:0302-4342 1996-01-01 Anticuerpos séricos contra Haemophilus influenzae en niños de la provincia de Valladolid487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49476]], camposKey:0302-4342 1996-01-01 Serum antibodies against haemophilus influenzae in children from the province of vallodolid (Spain) Anticuerpos séricos contra Haemophilus influenzae en niños de la provincia de Valladolid487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3294]], camposKey:0302-4342 1996-01-01 Serum eosinophil cationic protein (ECP) in children with allergic and non-allergic inflammation PROTEINA CATIONICA EOSINOFILA SERICA EN NINOS CON INFLAMACION ALERGICA Y NO ALERGICA245249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2853]], camposKey:0803-5253 1996-01-01 Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria728732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49477]], camposKey:0905-6157 1994-01-01 Antineutrophil cytoplasmic antibodies (ANCA) in idiopathic pulmonary hemosiderosis235239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49478]], camposKey:0888-7543 1992-01-01 A nonsense mutation (R1158X) and a splicing mutation (3849 + 4A ¿ G) in exon 19 of the cystic fibrosis transmembrane conductance regulator gene417418, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54889]], camposKey:0002-9297 1991-01-01 Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy11271132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49479]], camposKey:0340-6717 1991-01-01 The delta-F508 mutation and RFLP-linked loci in Spanish cystic fibrosis families516517, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22183]], camposKey:0302-4342 1990-01-01 Colostral IgA-Antibodies correlate better to total IgA and to seric antibodies to saliva´s ones3135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3300]], camposKey:0036-4355 1989-01-01 Absence of fibronectin in a 40-day-old child who died as a result of septicemia with disseminated intravascular coagulation Ausencia de fibronectina en un niño de 40 días fallecido durante una septicemia con coagulación intravascular diseminada.5962, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22181]], camposKey:0302-4342 1989-01-01 Measurement and comparison of IgG, IgM AND IgA class rheumatoid factor in juvenile chronic arthritis554558, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49480]], camposKey:0302-4342 1989-01-01 Measurement and comparison of IgG, IgM and IgA class rheumatoid factor in juvenile chronic arthritis MEDIDA Y COMPARACION DEL FACTOR REUMATOIDE DE CLASE IGG, IGM E IGA EN ARTRITIS CRONICA JUVENIL554558][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=20708]},camposKey: 539 540 IgA1 and IgA2 subclass antibodies to food proteins and salmonella antigens in secretions 978-94-010-7323-3Advances in Mucosal Immunology 1 1990-01-01 Springer][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62867]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62867]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635978]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631797]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145634962]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628661]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=902956851]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625836]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625788]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@810ab36][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63de16, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63df61, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dd8c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63df08, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dd68, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ded4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ddc7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63df85, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d76e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d778, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e1a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dfc4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373406, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373597, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e38c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372917, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37323b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e22e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d8e9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63da11, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b47, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372cd2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373112, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373123, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372fe9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e431, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b5a][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c11], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46595b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c00], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467be0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41316f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412f76], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41315e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41314d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41256f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412ee5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413731], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41314f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412500], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412b8c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4136a9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125f1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c2a0f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412402], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412437], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413da6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460794], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41212e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41235c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412319], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41235e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4121c8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46062e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460709], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411efb], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460496], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41219b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46045c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f421], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f379], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412628]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16e8a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16ca4, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14f0b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1398c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13ae5, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@138af][]
